Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
AC Immune
Biotech
Early data from AC Immune Alzheimer's vaccine suggest response
It’s early days for AC Immune’s Alzheimer’s disease vaccine, but a sneak peak at phase 1b/2 data showed the anti-amyloid beta vaccine elicited a response.
Annalee Armstrong
Jan 26, 2023 11:13am
Janssen moves 1 of 2 AC Immune Alzheimer's vaccines to next step
Nov 30, 2022 10:40am
Where are they now? Tracking down 2012's Fierce 15
Aug 29, 2022 3:00am
Genentech, AC Immune reveal more about crenezumab failure
Aug 2, 2022 11:00am
J&J's Janssen aims for 'sweet spot' of Alzheimer's R&D
Aug 1, 2022 8:00am
Will we ever land the Alzheimer's moonshot?
Jun 17, 2022 5:00am
